![Karen Chagin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Chagin
Directeur Technique/Scientifique/R&D chez
CONTEXT THERAPEUTICS INC.
Profil
Karen Chagin is currently Chief Medical Officer at Context Therapeutics, Inc. Formerly, Dr. Chagin was Senior Vice President-Early-Stage Development at Adaptimmune Therapeutics Plc.
Education includes an undergraduate degree from the University of Pennsylvania and a doctorate from Temple University School of Medicine.
Postes actifs de Karen Chagin
| Sociétés | Poste | Début |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 09/06/2025 |
Anciens postes connus de Karen Chagin
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Formation de Karen Chagin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
14
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University School of Medicine
 Temple University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
